2019
DOI: 10.1097/dad.0000000000001528
|View full text |Cite
|
Sign up to set email alerts
|

Biological Significance of the Association Between Cutaneous Al-amyloidoma and Sjögren Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(9 citation statements)
references
References 10 publications
0
9
0
Order By: Relevance
“…Exclusion of systemic amyloidosis, multiple myeloma, and other light chain-related diseases is mandatory [3,19]. There is usually no systemic involvement in cutaneous AL amyloidoma, which remains a form of localized amyloidosis with an indolent course [17,19]. Nonetheless, a minority of patients [4-15%] with AL amyloidoma may progress to systemic amyloidosis or other hematological dyscrasias [12,17].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Exclusion of systemic amyloidosis, multiple myeloma, and other light chain-related diseases is mandatory [3,19]. There is usually no systemic involvement in cutaneous AL amyloidoma, which remains a form of localized amyloidosis with an indolent course [17,19]. Nonetheless, a minority of patients [4-15%] with AL amyloidoma may progress to systemic amyloidosis or other hematological dyscrasias [12,17].…”
Section: Discussionmentioning
confidence: 99%
“…Tissue architecture is usually preserved [18], but it can also be replaced by the tumoral deposits of amyloid [16]. A sparse perivascular infiltrate consisting of lymphocytes and plasma cells, which are usually monotypic, is also visible in cutaneous AL amyloidoma [3,[17][18][19]. Lesions are indistinguishable from cutaneous nodular deposits in systemic AL amyloidosis [16].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In some cases, an association of PLCNA with chronic lymphocytic leukemia and some autoimmune disorders such as Sjogren syndrome, systemic lupus erythematosus, or limited scleroderma, among others, has been described. 2,6 The therapeutic approach of PLCNA is challenging because there is not a clearly effective treatment option, and local recurrence is common. Different treatment modalities have been described, including surgical excision, CO 2 laser, cryotherapy, dermabrasion, electrodesiccation and curettage, and pulsed dye laser.…”
Section: Discussionmentioning
confidence: 99%
“…Cutaneous deposits of AL-amyloid without systemic involvement, which have been termed AL-amyloidomas, are considered by some authors to represent an unusual manifestation of primary cutaneous marginal zone lymphoma (pcMZL) when accompanied by a variably dense lymphoplasmacytic infiltrate demonstrating evidence of light-chain restriction. [8][9][10] Herein, we report an additional case of primary cutaneous amyloid elastosis to frame a discussion of possible etiologic associations and highlight the variable clinical presentation and prognosis of this unique histopathologic entity.…”
Section: Introductionmentioning
confidence: 99%